← All Stories
Deal Flow

PE Hub: Ardian, Sagemount, Eir, Thoma Bravo back life sciences software

PE Hub reports private equity interest in life sciences software and says 1315 Capital closed a carve-out deal tied to Argonaut’s diagnostics division.

Two adults shaking hands with a stock market chart on a tablet, symbolizing a business deal.
Photo by AlphaTradeZone on Pexels

Ardian, Sagemount, Eir and Thoma Bravo are backing life sciences software, according to PE Hub. PE Hub also reported that 1315 Capital “closes a carve-out deal” involving a portfolio company of Telegraph Hill Partners and New Vale Capital, and that 1315 Capital is “eyes value creation potential in Argonaut’s diagnostics division,” according to PE Hub.

Life sciences software draws private equity backing

PE Hub’s headline stated that Ardian, Sagemount, Eir and Thoma Bravo “back life sciences software,” according to PE Hub. The PE Hub excerpt said AI and regulatory complexity are driving demand for life sciences software, which in turn has attracted private equity, according to PE Hub.

1315 Capital carve-out tied to Telegraph Hill Partners and New Vale Capital

PE Hub reported that 1315 Capital “closes a carve-out deal” with a portfolio company of Telegraph Hill Partners and New Vale Capital, according to PE Hub. PE Hub’s headline also referenced “value creation potential in Argonaut’s diagnostics division” in connection with 1315 Capital, according to PE Hub.

What is known and what is not disclosed in the source

PE Hub’s available text did not disclose a transaction value, financing amount, equity check size, or fund size for any of the firms named, according to the PE Hub page. The available text also did not provide the identity of the specific life sciences software company or companies backed by Ardian, Sagemount, Eir, or Thoma Bravo, according to PE Hub.

Source and publication details

The item was published on PE Hub under the Healthcare category and carried tags including Healthcare, PE Hub Wire, Technology, and US, according to the PE Hub page. The story was credited to John R Fischer and displayed as posted “1 day ago” on PE Hub, according to the PE Hub page.

(Background context, widely known): Life sciences software is commonly used by healthcare and biopharma organizations to support regulated workflows and data management. Artificial intelligence has been broadly adopted across software categories as vendors add automation and analytics capabilities.

Sources
Topics
Get capital raising signals before they hit the news.
Join Waitlist